XML 60 R44.htm IDEA: XBRL DOCUMENT v3.25.3
SEGMENT INFORMATION - COMPANY’S REPORTABLE SEGMENT INFORMATION (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenue, Major Customer [Line Items]        
Net sales $ 904 $ 951 $ 2,719 $ 2,888
Operating loss (218) (462) (283) (370)
Interest expense, net 23 18 66 53
Other income (11) (2) (10) (10)
Goodwill and intangible asset impairments 262 504 497 510
Restructuring and other costs 5 23 18 45
Amortization of intangibles     155 162
Loss before income taxes (230) (478) (339) (413)
Depreciation and Amortization 92 89 259 261
Operating Segments        
Revenue, Major Customer [Line Items]        
Net sales 904 951 2,719 2,888
Operating loss 176 198 614 574
All Other        
Revenue, Major Customer [Line Items]        
Unallocated corporate costs 69 79 224 227
Depreciation and Amortization 6 6 17 16
Segment Reconciling Items        
Revenue, Major Customer [Line Items]        
Interest expense, net 23 18 66 53
Other income (11) (2) (10) (10)
Goodwill and intangible asset impairments 262 504 497 510
Restructuring and other costs 5 23 18 45
Amortization of intangibles 57 54 156 162
Depreciation resulting from the fair value step-up of property, plant, and equipment from business combinations 1   2  
Connected Technology Solutions | Operating Segments        
Revenue, Major Customer [Line Items]        
Net sales 259 269 737 769
Adjusted cost of products sold 157 156 432 452
Adjusted selling expenses 55 60 167 183
Adjusted G&A expenses 20 19 58 57
Adjusted R&D expenses 17 18 51 56
Operating loss 10 16 29 21
Depreciation and Amortization 48 44 137 130
Essential Dental Solutions | Operating Segments        
Revenue, Major Customer [Line Items]        
Net sales 357 369 1,097 1,108
Adjusted cost of products sold 140 138 402 424
Adjusted selling expenses 77 76 220 239
Adjusted G&A expenses 18 17 55 56
Adjusted R&D expenses 6 6 17 17
Operating loss 116 132 403 372
Depreciation and Amortization 9 9 26 26
Orthodontic and Implant Solutions | Operating Segments        
Revenue, Major Customer [Line Items]        
Net sales 205 241 648 788
Adjusted cost of products sold 95 100 286 307
Adjusted selling expenses 56 75 164 238
Adjusted G&A expenses 20 29 59 96
Adjusted R&D expenses 12 13 35 39
Operating loss 22 24 104 108
Depreciation and Amortization 24 25 66 75
Wellspect Healthcare | Operating Segments        
Revenue, Major Customer [Line Items]        
Net sales 83 72 237 223
Adjusted cost of products sold 33 25 93 83
Adjusted selling expenses 13 12 39 39
Adjusted G&A expenses 7 7 20 21
Adjusted R&D expenses 2 2 7 7
Operating loss 28 26 78 73
Depreciation and Amortization $ 5 $ 5 $ 13 $ 14